未登录

Z

Zhaojin Yu

Henan Agricultural University

H指数:27

被引数:2,587

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Synthesis, Antioxidant and Bacteriostatic Activities of Pyridone Derivatives Based on Ethyl Maltol

JOURNAL OF HETEROCYCLIC CHEMISTRY

IF2.4

2025-10-010

PRE

Antibody-Drug Conjugates (ADCs): current and future biopharmaceuticals

抗体-药物结合物 (adc): 当前和未来的生物制药

JOURNAL OF HEMATOLOGY & ONCOLOGY

IF40.4

2025-04-300

OA

Synergistic potential of CDH3 in targeting CRC metastasis and enhancing immunotherapy

IF3.4

2025-03-280

OAAI

Current status and trends in small nucleic acid drug development: Leading the future

ACTA PHARMACEUTICA SINICA B

IF14.6

2024-09-011

OAAI

When will the immune-stimulating antibody conjugates (ISACs) be transferred from bench to bedside?

PHARMACOLOGICAL RESEARCH

IF10.5

2024-05-014

OAAI

Moisturizing and aroma-enhancing effects of low molecular weight fenugreek polysaccharides in cigarettes

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2024-02-013

PRE

An ICT-based ratiometric fluorescent probe for tracking and imaging SO2 during Cd-induced stress in plants

SENSORS AND ACTUATORS B-CHEMICAL

IF7.7

2023-11-0119

PRE

Cell adhesion molecules and immunotherapy in advanced non-small cell lung cancer: Current process and potential application

晚期非小细胞肺癌的细胞粘附分子和免疫治疗: 当前过程和潜在应用

FRONTIERS IN ONCOLOGY

IF3.3

2023-02-214

OAAI

Peptide-drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope?

ACTA PHARMACEUTICA SINICA B

IF14.6

2023-02-0188

OAAI

Advances of research of Fc-fusion protein that activate NK cells for tumor immunotherapy

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2022-08-0110

PRE

RETRACTION: miR-181a Induces Macrophage Polarized to M2 Phenotype and Promotes M2 Macrophage-mediated Tumor Cell Metastasis by Targeting KLF6 and C/EBPα (Retraction of Vol 5, 10.1038/MTNA.2016.71, 2016)

MOLECULAR THERAPY-NUCLEIC ACIDS

IF0

2022-06-011

OAAI

RNA interference-mediated FANCF silencing sensitizes OVCAR3 ovarian cancer cells to adriamycin through increased adriamycin-induced apoptosis dependent on JNK activation (vol 29, 1721, 2013)

ONCOLOGY REPORTS

IF3.9

2022-05-090

OAAI

MicroRNA-148a inhibits breast cancer migration and invasion by directly targeting WNT-1

ONCOLOGY REPORTS

IF3.9

2022-04-131

OAAI

Silencing KIF18B enhances radiosensitivity: Identification of a promising therapeutic target in sarcoma (vol 61, 103056, 2020)

IF10.8

2021-12-010

OAAI

Mannose-modified liposome designed for epitope peptide drug delivery in cancer immunotherapy

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2021-12-0111

PRE

HLA-A2.1-restricted ECM1-derived epitope LA through DC cross-activation priming CD8+ T and NK cells: a novel therapeutic tumour vaccine (vol 14, 71, 2021)

JOURNAL OF HEMATOLOGY & ONCOLOGY

IF40.4

2021-09-290

OAAI

Exosome loaded genipin crosslinked hydrogel facilitates full thickness cutaneous wound healing in rat animal model

IF8.1

2021-05-0757

OAAI

HLA-A2.1-restricted ECM1-derived epitope LA through DC cross-activation priming CD8+ T and NK cells: a novel therapeutic tumour vaccine

JOURNAL OF HEMATOLOGY & ONCOLOGY

IF40.4

2021-04-2817

OAAI

Peptide-based therapeutic cancer vaccine: Current trends in clinical application

CELL PROLIFERATION

IF5.6

2021-03-22125

OAAI

lncRNA-Xist/miR-101-3p/KLF6/C/EBPα axis promotes TAM polarization to regulate cancer cell proliferation and migration

MOLECULAR THERAPY-NUCLEIC ACIDS

IF0

2021-03-0199

OAAI